Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
50.5M
-
Number of holders
-
3
-
Total 13F shares, excl. options
-
253K
-
Shares change
-
-69.4K
-
Total reported value, excl. options
-
$7.49M
-
Value change
-
-$2.05M
-
Number of buys
-
1
-
Number of sells
-
-2
-
Price
-
$29.52
Significant Holders of Mirum Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (MIRM) as of Q4 2023
3 filings reported holding MIRM - Mirum Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share as of Q4 2023.
Mirum Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (MIRM) has 3 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 253K shares
of 50.5M outstanding shares and own 0.5% of the company stock.
Largest 10 shareholders include Frazier Life Sciences Management, L.P. (6.5M shares), BVF INC/IL (4.37M shares), EVENTIDE ASSET MANAGEMENT, LLC (2.66M shares), VANGUARD GROUP INC (2.48M shares), BlackRock Inc. (2.46M shares), JANUS HENDERSON GROUP PLC (2.06M shares), CADIAN CAPITAL MANAGEMENT, LP (1.93M shares), Rock Springs Capital Management LP (1.85M shares), STATE STREET CORP (1.73M shares), and Novo Holdings A/S (1.5M shares).
This table shows the top 3 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.